About COVID-RED

COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.
READ MORE >>

NEWS

READ MORE
Press release in The Guardian based on the scientific publication in BMJ Open
Jul
22
2022
Read more
READ MORE
Poster presentation at the ACOG Annual Clinical & Scientific Meeting
Jul
01
2022
Read more

Twitter

Brianna Goodale, Work Package 1 lead at @CovidRed and Director of Medical Affairs at @AvaWomen, has presented a poster at the annual meeting of @acog back in May.

The poster can now be accessed via our website: https://www.covid-red.eu/wp-content/uploads/2022/07/ACOG_2022_Kovacevic-et-al-scaled.jpg

Instagram

9 months ago
9 months ago
10 months ago

COVID-RED

Your support in the fight against COVID-19

The COVID-RED consortium

The COVID-RED consortium brings together nine organisations from four countries with the aim to deliver a large body of information on COVID-19 monitoring that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.

OUR CONSORTIUM
»

The COVID-RED project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005177. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.